NASDAQ | ETF
The fund normally invests at least 80% of its net assets (plus any borrowings for investment purposes) in the securities of health care companies.
The manager defines health care companies as companies engaged in health care innovations, such as developing new and effective therapies; pharmaceuticals; biotechnology; life sciences tools and services; managed health care; and/or health care equipment, supplies, providers, services, distributors, and facilities.
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 13.83% |
| UNH | UnitedHealth Group Incorporated | Healthcare | Healthcare Plans | 8.33% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 6.35% |
| ABT | Abbott Laboratories | Healthcare | Medical Devices | 4.48% |
| ISRG | Intuitive Surgical Inc | Healthcare | Medical Instruments & Supplies | 3.77% |
| BDX | Becton Dickinson and Company | Healthcare | Medical Instruments & Supplies | 3.74% |
| DHR | Danaher Corporation | Healthcare | Diagnostics & Research | 3.73% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 3.58% |
| ELAN | Elanco Animal Health | Healthcare | Drug Manufacturers - Specialty & Generic | 2.44% |
| CYTK | Cytokinetics Inc | Healthcare | Biotechnology | 2.44% |
| CVS | CVS Health Corp | Healthcare | Healthcare Plans | 1.96% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 1.88% |
| ASND | Ascendis Pharma AS | Healthcare | Biotechnology | 1.68% |
| A | Agilent Technologies Inc | Healthcare | Diagnostics & Research | 1.66% |
| EW | Edwards Lifesciences Corp | Healthcare | Medical Devices | 1.60% |
| HUM | Humana Inc | Healthcare | Healthcare Plans | 1.49% |
| HOLX | Hologic Inc | Healthcare | Medical Instruments & Supplies | 1.24% |
| ACLX | Arcellx Inc | Healthcare | Biotechnology | 1.21% |
| COR | Cencora Inc. | Healthcare | Medical Distribution | 1.20% |
| MTD | Mettler-Toledo International Inc | Healthcare | Diagnostics & Research | 1.19% |